×
Don't Miss Out!
Get your weekly Breakfast Briefing eNewsletter, filled with news, trends, and vital information from DIA!
Back to Agenda
Session 1: FDA Update
Session Chair(s)
Jennifer Shen, PhD
Director, Regulatory Affairs
ORIC Pharmaceuticals, United States
Speaker(s)
Eunice Lee, PhD
FDA, United States
Senior Scientific Advisor
Case Study
Judith Finlayson, PhD
Qiagen, United States
Senior Manager, Regulatory Affairs
Jonathan Perkins
QIAGEN, United Kingdom
Senior Manager, Personalized Healthcare
Andreas Koehler
Boehringer Ingelheim Pharma GmbH & Co. KG, Germany
Head of Biomarkers
Panel Discussion: Joining Session Speakers
Reena Philip, PhD
FDA, United States
Associate Director, Biomarkers and Precision Oncology, OCE
Gideon M. Blumenthal, MD
Merck & Co., Inc., United States
Vice President Clinical Development Oncology
Have an account?